Yonghee Cho, MD
Obstetrics & Gynecology · Raleigh, NCNPI 1265708796
Payments from drug & device makers
Across 44 payments — averaging $87.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myovant Sciences Inc.$2K
- Medtronic$2K
- AbbVie$120
- Sumitomo Pharma America, Inc.$90
- Astellas Pharma US Inc$57
- Mayne Pharma Commercial LLC$51
- plus $279 from 12 others
What the payments were for
- Speaking & faculty fees$1,64043%
- Travel & lodging$1,31934%
- Food & beverage$89023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myovant Sciences Inc. | 5 | $1,737 |
| Medtronic | 14 | $1,516 |
| AbbVie | 2 | $120 |
| Sumitomo Pharma America, Inc. | 4 | $90 |
| Astellas Pharma US Inc | 2 | $57 |
| Mayne Pharma Commercial LLC | 2 | $51 |
| Bayer | 2 | $39 |
| Merck | 2 | $31 |
| Abbott | 1 | $30 |
| Exeltis, USA Inc. | 2 | $29 |
| Coopersurgical, Inc. | 1 | $24 |
| LSI Solutions Inc | 1 | $23 |
| Evofem Biosciences, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $21 |
| Millicent US Inc | 1 | $17 |
| Davol Inc. | 1 | $16 |
| Avation Medical, Inc. | 1 | $14 |
| Organon | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,849 in reported general payments places this provider in the 85th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 30 | $2,038 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Raleigh
- Robert LittletonRaleigh$976K
- Ann CollinsRaleigh$701K
- Jack IngeRaleigh$157K
- Elizabeth CovielloRaleigh$26K
- Tanneisha BarlowRaleigh$22K
- Laura McKainWilmington$2.6M
- Robert ParkerWinston-Salem$2.1M
- Allison PuechlCharlotte$1.6M
- Jeffrey MichelsonNew Bern$1.2M
- Donald HornerCharlotte$907K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.